<code id='33C11C7FB3'></code><style id='33C11C7FB3'></style>
    • <acronym id='33C11C7FB3'></acronym>
      <center id='33C11C7FB3'><center id='33C11C7FB3'><tfoot id='33C11C7FB3'></tfoot></center><abbr id='33C11C7FB3'><dir id='33C11C7FB3'><tfoot id='33C11C7FB3'></tfoot><noframes id='33C11C7FB3'>

    • <optgroup id='33C11C7FB3'><strike id='33C11C7FB3'><sup id='33C11C7FB3'></sup></strike><code id='33C11C7FB3'></code></optgroup>
        1. <b id='33C11C7FB3'><label id='33C11C7FB3'><select id='33C11C7FB3'><dt id='33C11C7FB3'><span id='33C11C7FB3'></span></dt></select></label></b><u id='33C11C7FB3'></u>
          <i id='33C11C7FB3'><strike id='33C11C7FB3'><tt id='33C11C7FB3'><pre id='33C11C7FB3'></pre></tt></strike></i>

          Home / entertainment / leisure time

          leisure time


          leisure time

          author:leisure time    Page View:4733
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In